182 research outputs found
The contribution of astrocytes to the regulation of cerebral blood flow
In order to maintain normal brain function, it is critical that cerebral blood flow (CBF) is
matched to neuronal metabolic needs. Accordingly, blood flow is increased to areas where
neurons are more active (a response termed functional hyperemia). The tight relationships
between neuronal activation, glial cell activity, cerebral energy metabolism, and the
cerebral vasculature, known as neurometabolic and neurovascular coupling, underpin
functional MRI (fMRI) signals but are incompletely understood. As functional imaging
techniques, particularly BOLD fMRI, become more widely used, their utility hinges on
our ability to accurately and reliably interpret the findings. A growing body of data
demonstrates that astrocytes can serve as a “bridge,” relaying information on the level
of neural activity to blood vessels in order to coordinate oxygen and glucose delivery with
the energy demands of the tissue. It is widely assumed that calcium-dependent release
of vasoactive substances by astrocytes results in arteriole dilation and the increased
blood flow which accompanies neuronal activity. However, the signaling molecules
responsible for this communication between astrocytes and blood vessels are yet to
be definitively confirmed. Indeed, there is controversy over whether activity-induced
changes in astrocyte calcium are widespread and fast enough to elicit such functional
hyperemia responses. In this review, I will summarize the evidence which has convincingly
demonstrated that astrocytes are able to modify the diameter of cerebral arterioles. I
will discuss the prevalence, presence, and timing of stimulus-induced astrocyte calcium
transients and describe the evidence for and against the role of calcium-dependent
formation and release of vasoactive substances by astrocytes. I will also review alternative
mechanisms of astrocyte-evoked changes in arteriole diameter and consider the questions
which remain to be answered in this exciting area of research
Neuroglial ATP release through innexin channels controls microglial cell movement to a nerve injury
Microglia, the immune cells of the central nervous system, are attracted to sites of injury. The injury releases adenosine triphosphate (ATP) into the extracellular space, activating the microglia, but the full mechanism of release is not known. In glial cells, a family of physiologically regulated unpaired gap junction channels called innexons (invertebrates) or pannexons (vertebrates) located in the cell membrane is permeable to ATP. Innexons, but not pannexons, also pair to make gap junctions. Glial calcium waves, triggered by injury or mechanical stimulation, open pannexon/innexon channels and cause the release of ATP. It has been hypothesized that a glial calcium wave that triggers the release of ATP causes rapid microglial migration to distant lesions. In the present study in the leech, in which a single giant glial cell ensheathes each connective, hydrolysis of ATP with 10 U/ml apyrase or block of innexons with 10 µM carbenoxolone (CBX), which decreased injury-induced ATP release, reduced both movement of microglia and their accumulation at lesions. Directed movement and accumulation were restored in CBX by adding ATP, consistent with separate actions of ATP and nitric oxide, which is required for directed movement but does not activate glia. Injection of glia with innexin2 (Hminx2) RNAi inhibited release of carboxyfluorescein dye and microglial migration, whereas injection of innexin1 (Hminx1) RNAi did not when measured 2 days after injection, indicating that glial cells’ ATP release through innexons was required for microglial migration after nerve injury. Focal stimulation either mechanically or with ATP generated a calcium wave in the glial cell; injury caused a large, persistent intracellular calcium response. Neither the calcium wave nor the persistent response required ATP or its release. Thus, in the leech, innexin membrane channels releasing ATP from glia are required for migration and accumulation of microglia after nerve injury
Genome-wide analyses identify common variants associated with macular telangiectasia type 2
Idiopathic juxtafoveal retinal telangiectasis type 2 (macular telangiectasia type 2; MacTel) is a rare neurovascular degenerative retinal disease. To identify genetic susceptibility loci for MacTel, we performed a genome-wide association study (GWAS) with 476 cases and 1,733 controls of European ancestry. Genome-wide significant associations (P < 5 × 10−8) were identified at three independent loci (rs73171800 at 5q14.3, P = 7.74 × 10−17; rs715 at 2q34, P = 9.97 × 10−14; rs477992 at 1p12, P = 2.60 × 10−12) and then replicated (P < 0.01) in an independent cohort of 172 cases and 1,134 controls. The 5q14.3 locus is known to associate with variation in retinal vascular diameter, and the 2q34 and 1p12 loci have been implicated in the glycine/serine metabolic pathway. We subsequently found significant differences in blood serum levels of glycine (P = 4.04 × 10−6) and serine (P = 2.48 × 10−4) between MacTel cases and controls
Characterization of Calcium-Mediated Intracellular and Intercellular Signaling in the rMC-1 Glial Cell Line
The Baltimore declaration toward the exploration of organoid intelligence
We, the participants of the First Organoid Intelligence Workshop - "Forming an OI Community" (22-24 February 2022), call on the international scientific community to explore the potential of human brain-based organoid cell cultures to advance our understanding of the brain and unleash new forms of biocomputing while recognizing and addressing the associated ethical implications. The term "organoid intelligence" (OI) has been coined to describe this research and development approach (1) in a manner consistent with the term "artificial intelligence" (AI) - used to describe the enablement of computers to perform tasks normally requiring human intelligence. OI has the potential for diverse and far-reaching applications that could benefit humankind and our planet, and which urge the strategic development of OI as a collaborative scientific discipline. OI holds promise to elucidate the physiology of human cognitive functions such as memory and learning. It presents game-changing opportunities in biological and hybrid computing that could overcome significant limitations in silicon-based computing. It offers the prospect of unparalleled advances in interfaces between brains and machines. Finally, OI could allow breakthroughs in modeling and treating dementias and other neurogenerative disorders that cause an immense and growing disease burden globally. Realizing the world-changing potential of OI will require scientific breakthroughs. We need advances in human stem cell technology and bioengineering to recreate brain architectures and to model their potential for pseudo-cognitive capabilities. We need interface breakthroughs to allow us to deliver input signals to organoids, measure output signals, and employ feedback mechanisms to model learning processes. We also need novel machine learning, big data, and AI technologies to allow us to understand brain organoids
- …